{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:03:30Z","timestamp":1793102610472,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jinhua Science and Technology Project","award":["2023-3-068"],"award-info":[{"award-number":["2023-3-068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To evaluate the relationship between short-term longitudinal serum creatinine (Scr) trajectories and 28-day mortality in patients with acute kidney injury (AKI) on chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The data sources of this study were the Medical Information Mart for Intensive Care IV\u00a0(MIMIC-IV) database. Group-Based Trajectory Modeling was used to classify the trajectories of Scr indices within 96\u00a0h after Intensive Care Unit admission. Kaplan\u2013Meier survival curves were used to analyze the 28-day survival probabilities of patients with different Scr trajectories. Multivariate Cox proportional hazards models were applied to explore the association between different Scr trajectories and 28-day mortality. Receiver operating characteristic curves were employed to assess the predictive performance of the predictive model (model 3) for 28-day mortality. Decision curve analysis (DCA) was conducted to explore the clinical net benefit of the predictive model (model 3). Subgroup analysis was conducted to explore the robustness of the relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 7,852 patients with AKI on CKD were included in this study. Through GBTM analysis, five distinct trajectory groups were identified: Group G1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091762, 22.4%) with Scr levels maintained at approximately 1 and showing a stable trend (Scr low-stable group); Group G2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009915, 11.7%) with baseline Scr levels above 8 and showing a decreasing trend (Scr high-decreasing group); Group G3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092017, 25.7%) with Scr levels maintained at approximately 1.3\u20131.5 and showing a stable trend (Scr moderate-low stable group); Group G4 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091707, 21.7%) with Scr levels maintained at approximately 2 and showing a stable trend (Scr moderate-stable group); and Group G5 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091451, 18.5%) with Scr levels maintained at approximately 4 and showing a stable trend (Scr moderate-high stable group). The 28-day survival probabilities in Groups G1, G2, and G3 were higher than that in Groups G4 and G5. Compared with Group G1, the risk of 28-day mortality increased by 0.819-fold in Group G2, by 0.454-fold in Group G4, and by 0.860-fold in Group G5. The area under the curve (AUC) of model 3 was 0.795 (95% CI 0.782\u20130.807). DCA results showed that when the threshold probability ranged from 5 to 85%, the net benefit of model 3 was significantly higher than that of the \"treat all\" and \"treat none\" models. Group G4 and Group G5 were associated with increased 28-day mortality in both the male and female subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results showed that AKI on CKD patients with Scr high-decreasing trend, Scr moderate-stable trend, and Scr moderate-high stable trend had a higher risk of 28-day mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03632-x","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T02:04:25Z","timestamp":1765764265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of different serum creatinine trajectories with 28-day mortality in patients with acute kidney injury on chronic kidney disease: based on the MIMIC-IV database"],"prefix":"10.1186","volume":"31","author":[{"given":"Jun","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gancong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, et al. Chronic kidney disease. Nat Rev Dis Primers. 2025;11:8. https:\/\/doi.org\/10.1038\/s41572-024-00589-9.","journal-title":"Nat Rev Dis Primers"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"1501175","DOI":"10.3389\/fmed.2024.1501175","volume":"11","author":"J Guo","year":"2024","unstructured":"Guo J, Liu Z, Wang P, Wu H, Fan K, Jin J, et al. Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021. Front Med. 2024;11:1501175. https:\/\/doi.org\/10.3389\/fmed.2024.1501175.","journal-title":"Front Med"},{"key":"3632_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/dom.15625","volume":"26","author":"KJ Mayne","year":"2024","unstructured":"Mayne KJ, Hanlon P, Lees JS. Detecting and managing the patient with chronic kidney disease in primary care: a review of the latest guidelines. Diabetes Obes Metab. 2024;26:43\u201354. https:\/\/doi.org\/10.1111\/dom.15625.","journal-title":"Diabetes Obes Metab"},{"key":"3632_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0140-6736(24)02385-7","volume":"405","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Lumlertgul N, Jeong R, See E, Joannidis M, James M. Acute kidney injury. Lancet. 2025;405:241\u201356. https:\/\/doi.org\/10.1016\/s0140-6736(24)02385-7.","journal-title":"Lancet"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"149.e141","DOI":"10.1016\/j.urolonc.2022.10.011","volume":"41","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang T, Zhou H, Ni Z, Wang Q, Wu J, et al. Acute kidney injury as an independent predicting factor for stage 3 or higher chronic kidney disease after nephrectomy. Urol Oncol. 2023;41:149.e141-149.e149. https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.011.","journal-title":"Urol Oncol"},{"key":"3632_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031755","author":"TH Yeh","year":"2024","unstructured":"Yeh TH, Tu KC, Wang HY, Chen JY. From acute to chronic: unraveling the pathophysiological mechanisms of the progression from acute kidney injury to acute kidney disease to chronic kidney disease. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031755.","journal-title":"Int J Mol Sci"},{"key":"3632_CR7","doi-asserted-by":"publisher","first-page":"204062232096416","DOI":"10.1177\/2040622320964161","volume":"11","author":"YH Chang","year":"2020","unstructured":"Chang YH, Wu CH, Chou NK, Tseng LJ, Huang IP, Wang CH, et al. High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury. Ther Adv Chronic Dis. 2020;11:2040622320964161. https:\/\/doi.org\/10.1177\/2040622320964161.","journal-title":"Ther Adv Chronic Dis"},{"key":"3632_CR8","doi-asserted-by":"publisher","first-page":"e24206","DOI":"10.1002\/jcla.24206","volume":"36","author":"L He","year":"2022","unstructured":"He L, Yu J, Han G, Huang D, Han L, Zhang Q, et al. Analytical performance evaluation of different test systems on serum creatinine assay. J Clin Lab Anal. 2022;36:e24206. https:\/\/doi.org\/10.1002\/jcla.24206.","journal-title":"J Clin Lab Anal"},{"key":"3632_CR9","doi-asserted-by":"publisher","first-page":"e2326996","DOI":"10.1001\/jamanetworkopen.2023.26996","volume":"6","author":"O Efros","year":"2023","unstructured":"Efros O, Beckerman P, Basson AA, Cohen R, Klang E, Frenkel Nir Y, et al. Fluctuations in serum creatinine levels during hospitalization and long-term end-stage kidney disease and mortality. JAMA Netw Open. 2023;6:e2326996. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26996.","journal-title":"JAMA Netw Open"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"e29934","DOI":"10.1016\/j.heliyon.2024.e29934","volume":"10","author":"X Shen","year":"2024","unstructured":"Shen X, Li J, Yan H, Zhou S, Yang S, Li W. Combined blood pressure and heart rate trajectories are associated with prognosis in critically ill patients with acute aortic dissection: a group-based multi-trajectory analysis. Heliyon. 2024;10:e29934. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29934.","journal-title":"Heliyon"},{"key":"3632_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13054-024-04935-x","volume":"28","author":"K Takkavatakarn","year":"2024","unstructured":"Takkavatakarn K, Oh W, Chan L, Hofer I, Shawwa K, Kraft M, et al. Machine learning derived serum creatinine trajectories in acute kidney injury in critically ill patients with sepsis. Crit Care. 2024;28:156. https:\/\/doi.org\/10.1186\/s13054-024-04935-x.","journal-title":"Crit Care"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1097\/js9.0000000000001933","volume":"110","author":"JS Cho","year":"2024","unstructured":"Cho JS, Choi M, Shim JK, Park JH, Shin HJ, Choi HW, et al. Association of serum creatinine trajectories with 1-year mortality after valvular heart surgery: a retrospective cohort study. Int J Surg. 2024;110:7097\u2013105. https:\/\/doi.org\/10.1097\/js9.0000000000001933.","journal-title":"Int J Surg"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"11633","DOI":"10.1038\/s41598-022-15973-2","volume":"12","author":"WA Farooqui","year":"2022","unstructured":"Farooqui WA, Uddin M, Qadeer R, Shafique K. Latent class trajectories of biochemical parameters and their relationship with risk of mortality in ICU among acute organophosphorus poisoning patients. Sci Rep. 2022;12:11633. https:\/\/doi.org\/10.1038\/s41598-022-15973-2.","journal-title":"Sci Rep"},{"key":"3632_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jim-2019-001185","volume":"68","author":"O Laszczy\u0144ska","year":"2020","unstructured":"Laszczy\u0144ska O, Severo M, Mascarenhas J, Paiva JA, Azevedo A. Serum creatinine trajectories in real-world hospitalized patients: clinical context and short-term mortality. J Invest Med. 2020;68:870\u201381. https:\/\/doi.org\/10.1136\/jim-2019-001185.","journal-title":"J Invest Med"},{"key":"3632_CR15","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/ajcp\/aqab191.059","volume":"156","author":"MN Reganis","year":"2021","unstructured":"Reganis MN, Stickle D. Effect of 1 vs. 2 decimal place reporting of creatinine (mg\/dL) for calculation of estimated glomerular filtration rate (eGFR). Am J Clin Pathol. 2021;156:S30\u20131. https:\/\/doi.org\/10.1093\/ajcp\/aqab191.059.","journal-title":"Am J Clin Pathol"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/978-3-031-11665-0_53","volume-title":"Pediatric kidney disease","author":"I Guzzo","year":"2023","unstructured":"Guzzo I, Picca S, Askenazi D. Neonatal kidney dysfunction. In: Schaefer F, Greenbaum LA, editors. Pediatric kidney disease. Cham: Springer International Publishing; 2023. p. 1437\u201368."},{"key":"3632_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2174\/0113892037287215240424090908","volume":"25","author":"N Aziz","year":"2024","unstructured":"Aziz N, Wal P, Sinha R, Shirode PR, Chakraborthy G, Sharma MC, et al. A comprehensive review on the significance of cysteine in various metabolic disorders; particularly CVD, diabetes, renal dysfunction, and ischemic stroke. Curr Protein Pept Sci. 2024;25:682\u2013707. https:\/\/doi.org\/10.2174\/0113892037287215240424090908.","journal-title":"Curr Protein Pept Sci"},{"key":"3632_CR18","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.dld.2021.03.035","volume":"53","author":"MC Morelli","year":"2021","unstructured":"Morelli MC, Rendina M, La Manna G, Alessandria C, Pasulo L, Lenci I, et al. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Dig Liver Dis. 2021;53:S49\u201386. https:\/\/doi.org\/10.1016\/j.dld.2021.03.035.","journal-title":"Dig Liver Dis"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4266\/acc.003912","volume":"40","author":"MM Raouf","year":"2025","unstructured":"Raouf MM, Shadad EA, Ali NS. Effect of atorvastatin as a renal protective agent in patients with systemic inflammatory response syndrome using the renal arterial resistive index. Acute Crit Care. 2025;40:95\u2013104. https:\/\/doi.org\/10.4266\/acc.003912.","journal-title":"Acute Crit Care"},{"key":"3632_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/ijms23010531","volume":"23","author":"E Harlacher","year":"2022","unstructured":"Harlacher E, Wollenhaupt J, Baaten CCFMJ, Noels H. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review. Int J Mol Sci. 2022;23:531.","journal-title":"Int J Mol Sci"},{"key":"3632_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/toxins14040280","volume":"14","author":"C El Chamieh","year":"2022","unstructured":"El Chamieh C, Liabeuf S, Massy Z. Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings? Toxins. 2022;14:280.","journal-title":"Toxins"},{"key":"3632_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/toxins4110962","volume":"4","author":"G Cohen","year":"2012","unstructured":"Cohen G, H\u00f6rl WH. Immune dysfunction in uremia\u2014an update. Toxins. 2012;4:962\u201390.","journal-title":"Toxins"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","volume":"131","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu J, Chen Z, Feng J, Yang X, Liang W, et al. Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism. 2022;131:155194. https:\/\/doi.org\/10.1016\/j.metabol.2022.155194.","journal-title":"Metabolism"},{"key":"3632_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.amjms.2020.11.028","volume":"361","author":"Z-h Bai","year":"2021","unstructured":"Bai Z-h, Guo X-q. Dong R, Lei N, Pei Hh, Wang H: a nomogram to predict the 28-day mortality of critically ill patients with acute kidney injury and treated with continuous renal replacement therapy. Am J Med Sci. 2021;361:607\u201315. https:\/\/doi.org\/10.1016\/j.amjms.2020.11.028.","journal-title":"Am J Med Sci"},{"key":"3632_CR25","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s11604-023-01425-y","volume":"41","author":"Y Kuwatsuru","year":"2023","unstructured":"Kuwatsuru Y, Hirano T, Wakabayashi R, Ishisaki JY, Sokooshi H, Kuwatsuru R. Changes in renal function over time in outpatients with eGFR\u2009\u2265\u200930\u00a0mL\/min\/1.73 m2: implication for timing of renal function testing before contrast-enhanced CT imaging. Jpn J Radiol. 2023;41:994\u20131006. https:\/\/doi.org\/10.1007\/s11604-023-01425-y.","journal-title":"Jpn J Radiol"},{"key":"3632_CR26","first-page":"331","volume":"41","author":"J Wang","year":"2024","unstructured":"Wang J, Chen Y, Lu M, You D, Yang Z. A comparative study of three trajectory analysis methods. Chin J Health Stat. 2024;41:331\u20138.","journal-title":"Chin J Health Stat"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03632-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:40:38Z","timestamp":1768916438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03632-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03632-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}